Epidemic trends of obesity with impact on metabolism and digestive diseases

Digestive Diseases

Volumn 30, Issue 2, 2012, Pages 143-147

  Feneberg, Anja ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Epidemic trends; Metabolic syndrome; Obesity; Obesity related cancer; Obesity related digestive disease

Indexed keywords

ARTICLE; CANCER RISK; CHOLELITHIASIS; COLORECTAL CANCER; DISEASE ASSOCIATION; EPIDEMIC; ESOPHAGEAL ADENOCARCINOMA; GALLBLADDER CANCER; GASTRIC CARDIA ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HUMAN; LIVER CANCER; METABOLISM; NONALCOHOLIC FATTY LIVER; OBESITY; PANCREAS CANCER; PRIORITY JOURNAL;

DIGESTIVE SYSTEM DISEASES; HUMANS; METABOLISM; OBESITY; PROPORTIONAL HAZARDS MODELS;

EID: 84862895756     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000336660     Document Type: Article

References (30)

1. World Health Organization: Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser 2000; 894:i-xii, 1-253.
2. International Obesity Task Force. http://www.iaso.org/iotf/obesity, 2010.
3. Statistisches Bundesamt Deutschland: Ergebnisse des Mikrozensus, 2009.
4. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L, NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group: Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138: 24-32.
5. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, et al: Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211-2219.
6. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
7. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. www.idf.org, 2006.
8. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocr Relat Cancer 2009; 16: 1103-1123.
9. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975-981.
10. Haslam DW, James WPT: Obesity. Lancet 2005; 366: 1197-1209.
11. Frayn KN: Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 2005; 64: 7-13.
12. Ostrowska L, Czapska D, Karczewski JK: Body weight gain as the major risk factor of cholelithiasis in women and an important risk factor in man. Rocz Akad Med Bialymst 2005; 50: 54-56.
13. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC: Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652-658.
14. Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J: Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol 2012; 47: 197-202.
15. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A: The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 2012;56:952-964.
16. Lagergren J: Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011; 8: 340-347.
17. Nillson M, Johnsen R, Ye W, Hveem K, Lagergren J: Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003; 290: 66-72.
18. Corley DA, Kubo A: Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101: 2619-2628.
19. Nam SY, Choi IJ, Ryu KH, Park BJ, Kim HB, Nam BH: Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology 2010; 139: 1823-1826.
20. http://www.cancer.gov/cancertopics/factsheet/Risk/obesity, 2012.
21. Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.
22. Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF, Leitzmann M, Schatzkin A: A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 2008; 44: 465-471.
23. Weiderpass E, Partanen T, Kaaks R, Vainio H, Porta M, Kauppinen T, Ojajärvi A, Boffetta P, Malats N: Occurrence, trends and environmental etiology of pancreatic cancer. Scand J Work Environ Health 1998; 24: 165-174.
24. Batty GD, Kivimaki M, Morrison D, Huxley R, Smith GD, Clarke R, Marmot MG, Shipley MJ: Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall study. Cancer Epidemiol Biomarkers Prev 2009; 18: 673-675.
25. Moghaddam AA, Woodward M, Huxley R: Obesity and risk of colorectal cancer: a metaanalysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007; 16: 2533-2547.
26. Larsson SC, Wolk A: Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86: 556-565.
27. Wolin KY, Carson K, Colditz GA: Obesity and Cancer. Oncologist 2010; 15: 556-565.
28. Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, Serraino D, Franceschi S, Talamini R: The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009; 20: 353-357.
29. Schütte K, Bornschein J, Malfertheiner P: Hepatocellular carcinoma -epidemiological trends and risk factors. Dig Dis 2009; 27: 80-92.
30. Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, Ito H, Wakai K, Nagata C, Mizoue T, Sasazuki S, Inoue M, Tsugane S: Obesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012;42:212-221.